FDA Approves Generic Abortion Pill Amid Shutdown
- Here's a breakdown of the key information from the provided text, organized for clarity:
- A generic version of mifepristone, a drug used in medication abortions, has been approved by the FDA (though not announced wiht a typical press release).
- * Generic Manufacturer: Evita Solutions is producing the generic mifepristone.
Here’s a breakdown of the key information from the provided text, organized for clarity:
Main point:
A generic version of mifepristone, a drug used in medication abortions, has been approved by the FDA (though not announced wiht a typical press release). This approval comes amidst scrutiny and calls for a safety review from some state attorneys general.
Key Details:
* Generic Manufacturer: Evita Solutions is producing the generic mifepristone. The FDA has stated it’s “bioequivalent and therapeutically equivalent” to the brand-name Mifeprex.
* Usage: Mifepristone is used with Cytotec (misoprostol) to induce abortions up to 10 weeks gestation.
* Rising Popularity of Medication Abortion: Medication abortion (using drugs like mifepristone) accounted for 63% of all abortions in the U.S.in 2023, up from 53% in 2020.
* Safety Review: 22 Republican state attorneys general have requested a review of mifepristone’s safety,claiming it’s not as safe or effective as labeled. HHS Secretary Robert F. Kennedy,Jr.and FDA Commissioner Martin A. Makary, MD, MPH, have agreed to examine the concerns.
* Medical Organization Support: Major medical organizations like ACOG (American College of Obstetricians and Gynecologists) and Planned Parenthood maintain that mifepristone is safe and effective. ACOG hopes the generic version will increase accessibility and affordability.
* Accessibility: The generic mifepristone is available under the FDA’s Risk Evaluation and Mitigation Strategy (REMS) program.
People Mentioned:
* Robert F. Kennedy, Jr.: HHS Secretary
* Martin A. Makary, MD, MPH: FDA Commissioner
* Steven J. Fleischman, MD, MBA, Facog: ACOG President
* Jamila Vernon: Contact for steven J. Fleischman (jvernon@acog.org)
Sources:
* Evita Solutions: https://www.evitasolutionsllc.com/
* The New York Times: https://www.nytimes.com/2025/10/02/health/abortion-pill-generic-fda.html?unlocked_article_code=1.qU8.hz9h.vvyA2HUAn0SK&smid=url-share
* Healio (publication source)
date Context: The article was accessed on October 3, 2025, and references information published on September 30, 2025, and a New york Times article from October 2, 2025.This indicates the information is forward-looking (from the viewpoint of today, October 26, 2023).